AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freeman, V. L.
Right arrow Articles by Patel, V. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freeman, V. L.
Right arrow Articles by Patel, V. K.
May 2004, Vol 94, No. 5 | American Journal of Public Health 803-808
© 2004 American Public Health Association


RESEARCH AND PRACTICE

Racial Differences in Survival Among Men With Prostate Cancer and Comorbidity at Time of Diagnosis

Vincent L. Freeman, MD, MPH, Ramon Durazo-Arvizu, PhD, LaShon C. Keys, MEd, RD, Marc P. Johnson, BA, Kristian Schafernak, MD, MPH and Vikas K. Patel, MD

Vincent L. Freeman is with the Midwest Center for Health Services and Policy Research, Edward Hines Jr. VA Hospital, Hines, Ill. Vincent L. Freeman, Marc P. Johnson, Kristian Schafernak, and Vikas K. Patel are with the Department of Medicine, Loyola University Stritch School of Medicine, Maywood, Ill. Ramon Durazo-Arvizu is with the Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, Ill. LaShon C. Keys is with the Division of Community Health and Prevention, Illinois Department of Human Services, Tinley Park, Ill.

Correspondence: Requests for reprints should be sent to Vincent L. Freeman, MD, MPH, Midwest Center for Health Services and Policy Research, Edward Hines Jr. VA Hospital, PO Box 5000 (151 H), Hines, IL 60141 (e-mail: freeman{at}research.hines.med.va.gov).

Objectives. This study evaluated the effect of comorbidity at diagnosis on racial differences in survival among men with prostate cancer.

Methods. Clinical and demographic data were abstracted from records of 864 patients diagnosed at 4 Chicago area hospitals between 1986 and 1990. Comorbidity was scored on the basis of clinical information in the Charlson index. Cause-specific relative mortality adjusted for age, stage, differentiation, and treatment was compared across Charlson scores with Cox proportional hazards functions.

Results. Blacks had significantly greater mortality from prostate cancer and other causes (vs Whites, relative risk [95% confidence interval] = 1.84 [1.22, 2.79] and 1.69 [1.33, 2.29], respectively; P < .001). However, differences disappeared as initial comorbidity increased (1.75 [1.33, 2.31] vs 0.90 [0.59, 1.29] for scores = 0 and >= 5, respectively).

Conclusions. Absence of a significant preexisting medical diagnosis is associated with a higher risk for excess mortality among Black men diagnosed with prostate cancer.




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
A. S. Robbins, D. Yin, and A. Parikh-Patel
Differences in Prognostic Factors and Survival among White Men and Black Men with Prostate Cancer, California, 1995-2004
Am. J. Epidemiol., July 1, 2007; 166(1): 71 - 78.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Public Health Association